Lv1
20 积分 2024-01-25 加入
EXABS-147-AML How Do We Overcome Resistance to Venetoclax
5个月前
已完结
ELN Risk Stratification Is Not Predictive of Outcomes for Treatment-Naïve Patients with Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine
5个月前
已关闭
SOHO State of the Art Updates and Next Questions | Beyond BCL-2 Inhibition in Acute Myeloid Leukemia: Other Approaches to Leverage the Apoptotic Pathway
5个月前
已完结
SOHO State-of-the-Art Update and Next Questions: MPN
5个月前
已完结
Long-Term Follow-up of the Phase 3 Viale-a Clinical Trial of Venetoclax Plus Azacitidine for Patients with Untreated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
5个月前
已关闭
皖公网安备34019202002308
